Rights Contact Login For More Details
More About This Title Drug Truths: Dispelling the Myths About Pharma R & D
- English
English
- English
English
- English
English
ACKNOWLEDGMENTS ix
INTRODUCTION xi
PART I A MATTER OF THE HEART 1
CHAPTER 1 CHOLESTEROL DRUGS ARE UNNECESSARY 3
CHAPTER 2 INDUSTRY IS MORE INTERESTED IN "ME-TOO" DRUGS THAN IN INNOVATION 13
CHAPTER 3 IT TAKES INDUSTRY TOO LONG TO DISCOVER NEW DRUGS 23
PART II THE ROLE OF PHARMACEUTICAL R&D IN HEALTH CARE 39
CHAPTER 4 DRUGS ARE DISCOVERED BY ACADEMIA 41
CHAPTER 5 NEW MEDICINES ADD COSTS BUT LITTLE BENEFIT 50
CHAPTER 6 BIG PHARMA HAS FAILED AND SHOULD LEARN FROM BIOTECH SUCCESS 59
PART III THE PROFIT MOTIVE 69
CHAPTER 7 THE INDUSTRY INVENTS DISEASES 71
CHAPTER 8 NEW DRUGS ARE LESS SAFE THAN TRADITIONAL MEDICINES 79
CHAPTER 9 INDUSTRY SPENDS MORE ON ADVERTISING THAN ON R&D 91
CHAPTER 10 INDUSTRY DOES NOT CARE ABOUT DISEASES OF THE DEVELOPING WORLD 100
PART IV THE FUTURE 109
CHAPTER 11 BIG PHARMA'S DAY HAS PASSED 111
CHAPTER 12 FINAL REFLECTIONS 122
REFERENCES 124
INDEX 133
- English
English
?Drug Truths: Dispelling the Myths About Pharma R & D is an generally persuasive argument for the soul of the pharmaceutical industry.? (Journal of Clinical Research Best Practices, December 2009)
"I would recommend this book." (Chemistry World, June 2009)
"LaMattina stands out from many of the other observers of the industry." (Nature Chemistry, May 2009)
"The book provides unique insights into how big pharma manages its R&D. It also serves as a reminder of the useful role the drug industry play in keeping us healthy." (Chemical & Engineering News, April 20, 2009)
?The book offers an insider?s account of the reality of the drug discovery process?revealing it to be more risky, complicated and expensive than many critics suggest. Chapter by chapter, LaMattina addresses the common misconceptions about the pharmaceutical industry?setting the record straight.? (Kansas City InfoZine, February 2009)
?Along with a careful dissection of each false claim and a presentation of the overwhelming evidence that disproves it, LaMattina offers fascinating explanations of the way drug development and government approval function ? relying not on clever rhetoric, but on scientific fact and reliable evidence to support his claims; all the while remaining realistic about the industry's limitations.? (Medical News Today, February 2009)
"It's obvious from reading his book that LaMattina believes in his industry, in Big Pharma, and in the research and development that has led to drugs that have cured infectious diseases, delayed encroaching heart disease, controlled arthritis?for many millions?reduced pain and suffering." (TheDay.com, January 25, 2009)
"John L. LaMattina … the recently retired head of Pfizer’s global research and development… by using well illustrated examples, takes us through the realities and myths about many of the issues surrounding the pharmaceutical industry. Rather than innuendo, he offers data. This is an important and timely book … In the end this book is about science where data rules. … [and] should become indispensable to those who wish to either understand or set policy."—Dr. Richard A. Lerner, President of The Scripps Research Institute
"Drug Truths is an authoritative, clear and accessible exposition of the realities of drug discovery and development. It is factual and balanced, although LaMattina does not shy away from criticizing some of the misguided views that have appeared in print. The main points are well documented and logically presented. The book is a splendid addition to the contemporary health care literature."
—E. J. Corey, Harvard University